Cancellation of state registration. Zodak®

October 26, 2017

Active substances:

Cetirizine

Trade names:

Zodak®

ICD-10:

VII.H10-H13.H10.1 Acute atopic conjunctivitis

X.J30-J39.J30.1 Allergic rhinitis caused by pollen of plants

X.J30-J39.J30.3 Other allergic rhinitis

XII.L20-L30.L20.8 Other atopic dermatitis

XII.L20-L30.L23 Allergic contact dermatitis

XII.L20-L30.L24 Simple irritant contact dermatitis

XII.L20-L30.L28.0 Simple chronic lichen

XII.L20-L30.L29 Itching

XII.L50-L54.L50 Hives

XIX.T66-T78.T78.3 Angioedema

Zodak, cetirizine, antiallergic drug, antihistamine drug, allergy, allergy treatment, allergic rhinitis, allergic conjunctivitis, pollinosis, allergic dermatitis, urticaria

The Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Law of 12.04.2010 No. 61-FZ "On the circulation of medicinal products" decided to abolish state registration and exclusion from the state register of medicines for medical use of the medicinal product (registration certificate LS-000432 dated 07.06.2010 issued by Zentiva, Czech Republic):

Zodak® (trade name of the medicinal product)

Cetirizine (international non-proprietary or grouping or chemical name)

syrup, 5 mg / 5 ml (dosage form, dosage)

Zentiva, Czech Republic U kabelovny 130, 102 37 Prague 10, Dolni Mecholupy, Czech Republic (name and address of the location of the manufacturer of the medicinal product)

on the basis of an application by the authorized legal entity of the Sanofi-aventis Group JSC to cancel the state registration of the medicinal product.